Amprion has been awarded a $100,000 research grant to support studies on the causes of sporadic amyotrophic lateral…
Articles by Andrea Lobo, PhD
AcuraStem has received $4 million in funding from the California Institute for Regenerative Medicine (CIRM) to advance the development…
Treatment with Qalsody (tofersen) substantially slowed disease progression and reduced markers of nerve damage in people with amyotrophic…
The ALS Therapy Development Institute (ALS TDI), a nonprofit biotech, has developed a comprehensive resource designed to help people with…
Biotechnology company ProJenX has received a $1 million grant from the ALS Association to support a portion of…
BrainStorm Cell Therapeutics has reached an alignment with the U.S. Food and Drug Administration (FDA) on the chemistry, manufacturing,…
Tiziana Life Sciences has applied for a grant from the ALS Association to fund an early-stage clinical trial…
Eli Lilly has acquired the global exclusive rights to develop and market QRL-204, QurAlis’ investigational therapy for…
Spinogenix will soon launch a Phase 1/2 clinical trial in the U.S. to test its investigational small molecule SPG302…
The ALS Association has selected InnoVision Marketing Group as its agency of record for creating media campaigns to raise…